雜志介紹

Cancer Investigation雜志介紹

《Cancer Investigation》是(shi)一本(ben)以(yi)English為(wei)主(zhu)的(de)(de)(de)(de)未開(kai)放獲取國際優秀期刊(kan)(kan)(kan)，中文名稱(cheng)癌癥調查(cha)，本(ben)刊(kan)(kan)(kan)主(zhu)要出(chu)版(ban)、報道醫學(xue)(xue)-ONCOLOGY領域的(de)(de)(de)(de)研(yan)究動(dong)態以(yi)及在該(gai)(gai)領域取得的(de)(de)(de)(de)各方(fang)面的(de)(de)(de)(de)經驗和科研(yan)成(cheng)果(guo)，介紹該(gai)(gai)領域有(you)關(guan)本(ben)專業(ye)的(de)(de)(de)(de)最新(xin)進展，探(tan)討(tao)行業(ye)發(fa)展的(de)(de)(de)(de)思路和方(fang)法(fa)，以(yi)促進學(xue)(xue)術信息交(jiao)流，提高行業(ye)發(fa)展。該(gai)(gai)刊(kan)(kan)(kan)已被國際權威數據庫SCIE收錄，為(wei)該(gai)(gai)領域相(xiang)關(guan)學(xue)(xue)科的(de)(de)(de)(de)發(fa)展起(qi)到了良好(hao)的(de)(de)(de)(de)推動(dong)作(zuo)用，也得到了本(ben)專業(ye)人員的(de)(de)(de)(de)廣(guang)泛認(ren)可。該(gai)(gai)刊(kan)(kan)(kan)最新(xin)影響因子為(wei)1.8，最新(xin)CiteScore 指(zhi)數為(wei)3.8。

本刊近期中國學者發表(biao)的(de)論文(wen)主(zhu)要有：

• Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study

  Author: Yang, Liping; Sun, Haifeng; Bai, Yan; Sun, Shengzhi; Wu, Xiaoming; Gan, Zhenhai; Du, Jianqiang; Du, Jianfei

• Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma

  Author: Qiu, Huizhu; Gu, Guojian; Zuo, Erdong; Cheng, Xu

• The Prognostic Value of ADAMTS8 and Its Role as a Tumor Suppressor in Breast Cancer

  Author: Zhang, Qia; Kanyomse, Quist; Luo, Chenghao; Mo, Qingfan; Zhao, XunPing; Wang, Long; Peng, Weiyan; Ren, Guosheng

• A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia

  Author: Wang, Jun; Wu, Jiafei; Wang, Yijing; Wang, Yu; Jiang, Chuanyan; Zou, Mengying; Jin, Xiaokang; Sun, Xiaoran; Zhang, Yu; Ma, Sijia; Wang, Guoqiang; Zhu, Xin; Lu, Huafei; Xu, Chunwei; Wang, Wenxian; Li, Leo; Han, Yusheng; Cai, Shangli; Li, Hui

英文介紹

Cancer Investigation雜志英文介紹

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.